Dr. Rana Abu Manneh is a postdoctoral researcher at the Cyprus Institute of Neurology & Genetics (CING). She completed her PhD in Molecular Medicine at CING in 2024, where her research focused on elucidating the genetic landscape of early-onset Parkinson’s disease in the Cypriot population. Her work has resulted in a peer-reviewed publication, and she continues to pursue research in neurodegenerative diseases and epigenetics. In parallel, she serves as a Clinical Research Coordinator at CING, overseeing multiple clinical trials in hereditary transthyretin amyloidosis and myasthenia gravis, among other conditions.
Dr. Rana Abu Manneh is a postdoctoral researcher at the Cyprus Institute of Neurology & Genetics (CING). She completed her PhD in Molecular Medicine at CING in 2024, where her research focused on elucidating the genetic landscape of early-onset Parkinson’s disease in the Cypriot population. Her work has resulted in a peer-reviewed publication, and she continues to pursue research in neurodegenerative diseases and epigenetics. In parallel, she serves as a Clinical Research Coordinator at CING, overseeing multiple clinical trials in hereditary transthyretin amyloidosis and myasthenia gravis, among other conditions.